| Product Specifications | |
| Application | WB |
| Clonality | Monoclonal IgG1 |
| Host | Mouse |
| Immunogen | Recombinant Midoriishi-Cyan |
| Formulation | 100 μg IgG in 100 μl volume of PBS containing 50% glycerol, pH 7.2. No preservative is contained. |
| Citations for Anti-Midoriishi-Cyan mAb (Clone: 5B7) – 3 Found |
| Ideno, Hisashi; Nakashima, Kazuhisa; Komatsu, Koichiro; Araki, Ryoko; Abe, Masumi; Arai, Yoshinori; Kimura, Hiroshi; Shinkai, Yoichi; Tachibana, Makoto; Nifuji, Akira. G9a is involved in the regulation of cranial bone formation through activation of Runx2 function during development. Bone. 2020;137:115332. PubMed - Comments: Used in: WB |
| Ideno, Hisashi; Nakashima, Kazuhisa; Komatsu, Koichiro; Araki, Ryoko; Abe, Masumi; Arai, Yoshinori; Kimura, Hiroshi; Shinkai, Yoichi; Tachibana, Makoto; Nifuji, Akira. G9a is involved in the regulation of cranial bone formation through activation of Runx2 function during development. Bone. 2020;137:115332. PubMed - Comments: Used in: Co-IP |
| Ideno, Hisashi; Nakashima, Kazuhisa; Komatsu, Koichiro; Araki, Ryoko; Abe, Masumi; Arai, Yoshinori; Kimura, Hiroshi; Shinkai, Yoichi; Tachibana, Makoto; Nifuji, Akira. G9a is involved in the regulation of cranial bone formation through activation of Runx2 function during development. Bone. 2020;137:115332. PubMed - Comments: Used in: ChIP |